Drug intelligence / Profile preview

Motherwell

Development stage
Unknown
Lead developer
Center for Addiction and Mental Health
Modality
Small Molecules
Administration
Oral
01

Overview

Motherwell is a multi-ingredient dietary supplement (nutraceutical) developed by the Centre for Addiction and Mental Health (CAMH) in Toronto to prevent and reduce postpartum blues (PPB) and associated mood symptoms. Invented by Dr. Jeffrey Meyer, the supplement is formulated with a combination of blueberry juice and extract (providing antioxidants), tryptophan (2 g), and tyrosine (10 g). It is specifically designed to be administered over days 3–5 postpartum to counteract the surge of monoamine oxidase A (MAO-A) protein in the brain. This surge typically depletes mood-supporting neurotransmitters such as serotonin, norepinephrine, and dopamine; Motherwell provides the necessary amino acid precursors and antioxidants to maintain these levels. The product has been licensed to the international women's health company Exeltis and is marketed under the brand name Blues Away®.

Brand names
Blues Away
Other names
Motherwell dietary supplement
02

Targets

MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on Motherwell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Motherwell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call